130 search results for: Burden of Disease

Join experts Prof. Salvatore Oliva and Dr. Milli Gupta for an educational symposium on the on type 2 inflammation in EoE.
On Demand
UEGW 2024 | Something to Chew On: Exploring Biologics in EoE Management

Prof. Salvatore Oliva and Dr. Milli Gupta discuss the importance of long-term care, multidimensional assessment, and the latest data for biologics.

Keeping an Eye on Pediatric EoE
Gastroenterology
Keeping an Eye on Pediatric EoE
expert video

Global experts Prof. Arjan Bredenoord and Drs. Ikuo Hirano, Kathryn Peterson, and Evan Dellon discuss identification and assessment of pediatric EoE.

View more
Food Bolus Impaction: An Opportunity to Diagnose EoE
Gastroenterology
Food Bolus Impaction: An Opportunity to Diagnose EoE
expert video

Dr. Evan Dellon highlights how resolution of food impaction can be leveraged as an opportunity to diagnose EoE.

View more
Why Is It Important to Assess Lung Function in Pediatric Asthma?
Pulmonology
Why Is It Important to Assess Lung Function in Pediatric Asthma?
interactivity

Learn about FEV1pp and the downstream effects of lung function decline in children with severe asthma.

View more
IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP
On Demand
IFOS 2023 | Type 2 Inflammation and Clinically Relevant Improvements in CRSwNP

Dr. Stella Lee and Profs. Peter Hellings and Wytske Fokkens discuss type 2 inflammation, partnering with patients to improve outcomes, and real-world data on biologic effectiveness in CRSwNP.

ESPGHAN 2026
On Demand
Pediatric EoE: An Interactive Learning Symposium

Join leading experts in pediatric eosinophilic esophagitis (EoE), Professors Salvatore Oliva, MD, PhD, and André Hörning, MD, as they explore the multifaceted journey of pediatric patients with EoE through a hypothetical patient case, navigating real-world challenges in managing EoE.

Hindered Growth in Children Aged <12 Years with Moderate-to-Severe AD and Potential Improvement with Dupilumab Treatment
Dermatology
Hindered Growth in Children Aged <12 Years with Moderate-to-Severe AD and Potential Improvement with Dupilumab Treatment
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Dr Amy Paller discusses how moderate-to-severe AD may hinder growth in pediatric patients and highlights data showing treatment with dupilumab may increase vertical growth in children of lower stature.

View more
FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients
Pulmonology
FeNO Is a Noninvasive Biomarker That Can Support Diagnosis and Management for Asthma Patients
Infographic

Learn how FeNO, a noninvasive biomarker for type 2 inflammation, can be used to optimize care for asthma patients.

View more
ADVENT at ERS 2024
On Demand
ERS 2024 | Airway Remodeling: A Permanent or Transitory Consequence in Severe Asthma Patients?

Join Klaus Rabe, MD, PhD, FERS; Celeste Porsberg, MD, PhD; and Mario Castro, MD, MPH, for a symposium on airway remodeling in severe asthma patients.